Tekla Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Tekla Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-25,051	Closed	-$3.07M	–	228
2020 Q2	$3.07M	Sell	25,051 -25,050	-50%	-$2.84M	0.12%	138
2020 Q1	$4.39M	Hold	50,101	–	–	0.2%	94
2019 Q4	$5.24M	Sell	50,101 -14,398	-22%	-$1.61M	0.2%	101
2019 Q3	$7.42M	Hold	64,499	–	–	0.32%	63
2019 Q2	$11.1M	Buy	64,499 +29,608	+85%	+$5.12M	0.45%	53
2019 Q1	$5.88M	Sell	34,891 -28,454	-45%	-$4.23M	0.24%	88
2018 Q4	$6.17M	Buy	63,345 +19,747	+45%	+$2.59M	0.26%	77
2018 Q3	$7.53M	Sell	43,598 -27,899	-39%	-$4.02M	0.27%	79
2018 Q2	$9.98M	Sell	71,497 -39,287	-35%	-$5.58M	0.38%	61
2018 Q1	$12.5M	Buy	110,784 +85,784	+343%	+$10.8M	0.49%	48
2017 Q4	$3.3M	Buy	+25,000	New	+$2.94M	0.13%	104
2016 Q1	–	Sell	-30,000	Closed	-$2.08M	–	141
2015 Q4	$2.08M	Sell	30,000 -64,000	-68%	-$5.21M	0.08%	121
2015 Q3	$8.59M	Buy	+94,000	New	+$10.5M	0.31%	75

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Tekla Capital Management's GWPH Position: Q3 2020 in Review

Tekla Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 25,051 shares — an estimated $3.07M sold.

Tekla Capital Management first reported a position in GWPH in Q3 2015 and held it in 13 quarters. The position peaked at $12.5M in Q1 2018. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

Tekla Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Tekla Capital Management sold 25,051 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $3.07M.
Tekla Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2015 and held it in 13 quarters.
Tekla Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $12.5M in Q1 2018.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Tekla Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.